Courtney Hollowell, MD
Urology · Chicago, ILNPI 1326057712
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Medline Industries LP at 58.3% of the total.
Across 4 payments — averaging $1311.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medline Industries LP$3K
- Astellas Pharma Global Development$2K
- Boston Scientific$125
Across 87 payments — averaging $22,353 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.6M
- Merck$206K
- Dendreon Pharmaceuticals LLC$105K
- Astellas Pharma Global Development$53K
What the payments were for
- Consulting fees$2,06039%
- Speaking & faculty fees$3,06058%
- Food & beverage$1252%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medline Industries LP | 2 | $3,060 |
| Astellas Pharma Global Development | 1 | $2,060 |
| Boston Scientific | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dermatology and Wound Care$3,060
- XTANDI$2,060
- GENERAL MALE SUI$125
How this compares
$5,245 in reported general payments places this provider in the 65th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Chicago
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
- Joshua MeeksChicago$248K
- Edward SchaefferChicago$209K
- Paul YonoverChicago$179K
- Omer RaheemChicago$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.